Form 4: Emerson Director Levatich Receives RSU Grant
Insider Transaction Report
Emerson Electric Co. Director Matthew S. Levatich was granted 1,251 restricted stock units, increasing his direct beneficial ownership to 25,825 shares.
Summary
- Matthew S. Levatich, a Director of Emerson Electric Co. (EMR), received a grant of 1,251 restricted stock units (RSUs).
- The transaction occurred on February 3, 2026.
- Each RSU had a fair market value of $151.795 on the grant date.
- This grant was made under a shareholder-approved benefits plan and is compliant with Rule 16b-3(d) of the Securities Exchange Act of 1934.
- Following this transaction, Mr. Levatich directly beneficially owns a total of 25,825 shares of Emerson Electric Co. common stock.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting routine director compensation that aligns interests with shareholders, without indicating any significant operational or financial changes.
Positives
- The grant of restricted stock units aligns the director's interests with long-term shareholder value creation.
- The grant was made under a shareholder-approved benefits plan, indicating adherence to good corporate governance practices.
- The transaction is compliant with SEC Rule 16b-3(d), a regulatory provision for insider transactions.
Negatives
- No negative aspects are disclosed in this routine insider transaction filing.
Risks
- No specific risks are mentioned in this Form 4 filing, which primarily reports an insider compensation event.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that grants of restricted stock units to directors are a common form of executive and director compensation across various industries, particularly in established companies like Emerson Electric Co. This practice aims to align the interests of leadership with long-term shareholder value creation. Such routine compensation disclosures typically do not indicate broader industry trends but rather reflect standard corporate governance practices.
Comparison to Industry Standards
- Grants of restricted stock units are a standard component of director compensation packages in large-cap industrial companies.
- Similar RSU grants are observed at peers like Honeywell International Inc. (HON) and Siemens AG (SIEGY), where director compensation often includes a mix of cash and equity to foster long-term commitment.
- The fair market value of $151.795 per unit is specific to EMR's stock price at the time of grant and is comparable to equity compensation values seen in similar-sized companies based on their respective stock prices.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Adherence | The grant was made under a shareholder-approved benefits plan, which is a positive aspect of corporate governance, demonstrating adherence to established compensation policies. | 02/03/2026 | Reinforces alignment of director incentives with shareholder interests and demonstrates compliance with governance best practices. |
Legal Proceedings
- No litigation or regulatory matters are disclosed in this Form 4 filing.
Related Party Transactions
- The filing reports the grant of 1,251 restricted stock units to Matthew S. Levatich, a Director, which constitutes a related party transaction in the form of executive compensation.
Stakeholder Impact
- Shareholders: The grant aligns the director's interests with long-term shareholder value, potentially fostering more committed leadership.
- Employees: No direct impact on general employees is indicated by this compensation filing.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this compensation filing.
Next Steps
- No specific future actions, events, or milestones are mentioned in this Form 4 filing beyond the reported transaction.
Key Dates
| Date | Description |
|---|---|
| 02/03/2026 | Date of earliest transaction (grant of restricted stock units to Matthew S. Levatich) |
| 02/05/2026 | Date the Form 4 was signed by the attorney-in-fact for Matthew S. Levatich |
Recommendation
holdThis Form 4 filing details a routine grant of restricted stock units to a director, which is a standard compensation practice and does not provide new information that would fundamentally alter the investment thesis for Emerson Electric Co. It reinforces alignment of director interests with shareholders but does not suggest a significant catalyst for a 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Emerson Electric Co., EMR, Matthew S. Levatich, Director, Restricted Stock Units, RSU Grant, Insider Transaction, Form 4, Beneficial Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.